Pediatric familial hypercholesterolemia indication for Crestor
Links shared publicly online about this topic.
- 1,672total visits
Pediatric familial hypercholesterolemia indication for Crestor
View full resource at theheart.org
Tags: Cholesterol Medication, Children's Health, FDA, Crestor
Most Recently Shared on October 16, 2009 at 9:14 pm By:
heartwire: Rosuvastatin cleared for pediatric FH http://bit.ly/4EbBZV
Pfizer's new chewable Lipitor for children receives European Commission approval
news-medical.net — “Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.” View full resource at news-medical.net
Most Recently Shared on July 7, 2010 at 10:33 am By:
Stroke News: Pfizer's new chewable Lipitor for children receives European Commission approval: Pfizer Inc. annou... http://twurl.nl/zky5r3
U.S. Food and Drug Administration Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
drugs.com — “Crestor (rosuvastatin calcium) is used to treat pediatric patients with heterozygous familial hypercholesterolemia. Includes Crestor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:03 pm By:
FDA Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia - http://bit.ly/DrHi0
Crestor approved for pediatric patients with Heterozygous Familial Hypercholesterolemia - MPR
empr.com — “The FDA has approved Crestor (rosuvastatin calcium tablets, from AstraZeneca) for use in pediatric patients 10"17 years of age with heterozygous familial hypercholesterolemia (HeFH) after failing an adequate trial of diet therapy.” View full resource at empr.com
Most Recently Shared on October 16, 2009 at 4:02 pm By:
MPR News: Crestor approved for pediatric patients with Heterozygous Familial Hypercholesterolemia : The.. http://bit.ly/1V4B8g
CRESTOR® approved for use in pediatric patients with HeFH
astrazeneca-us.com — “Read how the FDA decision was based on a supplemental New Drug Application submitted by AstraZeneca which included data from the PLUTO study.” View full resource at astrazeneca-us.com
Most Recently Shared on October 16, 2009 at 1:05 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves CRESTOR® for use in pediatric patients with heterozygous familial hypercholesterolemia http://bit.ly/4aRRkt
Welchol (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
drugs.com — “Welchol (colesevelam HCl) is used to treat Pediatric Patients with Heterozygous Familial Hypercholesterolemia. Includes Welchol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 7, 2009 at 10:47 pm By:
FDA Approves Welchol for Pediatric Patients with Heterozygous Familial Hypercholesterolemia - http://bit.ly/BU6lG
Advertisement
